{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:39:58Z","timestamp":1759178398787,"version":"3.41.2"},"reference-count":32,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:p>This is a novel case of a 16-month-old boy with a history of prematurity with intrauterine growth restriction, severe failure to thrive, microcephaly, pachygyria, agenesis of the corpus callosum, and postnatal embolic stroke, who presented with new-onset diabetes mellitus with diabetic ketoacidosis in the setting of severe acute respiratory syndrome coronavirus 2 infection, with a course complicated by atypical hemolytic syndrome (aHUS). This patient demonstrated remarkable insulin resistance in the period before aHUS diagnosis, which resolved with the first dose of eculizumab therapy. There is increasing evidence that COVID-19 is associated with thrombotic disorders and that microangiopathic processes and complement-mediated inflammation may be implicated. In this case report, we describe a pediatric patient with COVID-19 and a new complement-mediated microangiopathic thrombotic disease. Because whole-exome sequencing and extensive workup returned without a clear etiology for aHUS, this is likely a COVID-19 triggered case of aHUS versus an idiopathic case that was unmasked by the infection.<\/jats:p>","DOI":"10.1542\/peds.2020-016774","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T12:25:13Z","timestamp":1602246313000},"source":"Crossref","is-referenced-by-count":23,"title":["Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19"],"prefix":"10.1542","volume":"147","author":[{"given":"Faraz","family":"Alizadeh","sequence":"first","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts; and"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"O\u2019Halloran","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts; and"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areej","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts; and"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Chen","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts; and"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Trissal","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts; and"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avram","family":"Traum","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts; and"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"DeCourcey","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts; and"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"issue":"13","key":"2021121013261464700_B1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u202f314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"2021121013261464700_B2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jamapediatrics.2020.1948","article-title":"Characteristics and outcomes of children with Coronavirus Disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units","volume":"174","author":"Shekerdemian","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"10","key":"2021121013261464700_B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dom.14057","article-title":"COVID-19 infection may cause ketosis and ketoacidosis","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"2021121013261464700_B4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4093\/dmj.2020.0091","article-title":"Acute hyperglycemic crises with coronavirus disease-19: case reports","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab J"},{"issue":"2","key":"2021121013261464700_B5","first-page":"146","article-title":"[The management of blood glucose should be emphasized in the treatment of COVID-19]","volume":"51","author":"Ma","year":"2020","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"2021121013261464700_B6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.dsx.2020.04.049","article-title":"COVID-19 and diabetes mellitus: an unholy interaction of two pandemics","volume":"14","author":"Pal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"2021121013261464700_B7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.dsx.2020.03.002","article-title":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic","volume":"14","author":"Gupta","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"23","key":"2021121013261464700_B8","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"issue":"6","key":"2021121013261464700_B9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"issue":"2","key":"2021121013261464700_B10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction","volume":"77","author":"Menter","year":"2020","journal-title":"Histopathology"},{"issue":"22","key":"2021121013261464700_B11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will complement inhibition be the new target in treating COVID-19-related systemic thrombosis?","volume":"141","author":"Campbell","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"2021121013261464700_B12","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1111\/bjh.16783","article-title":"Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily","volume":"189","author":"Gavriilaki","year":"2020","journal-title":"Br J Haematol"},{"key":"2021121013261464700_B13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2020.04.027","article-title":"Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis","volume":"507","author":"Henry","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"15","key":"2021121013261464700_B14","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood-2018-11-884700","article-title":"Characterization and treatment of congenital thrombotic thrombocytopenic purpura","volume":"133","author":"Alwan","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2021121013261464700_B15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression","volume":"14","author":"Huang","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"2021121013261464700_B16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/en.2006-0692","article-title":"Interleukin-1\u03b2-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression","volume":"148","author":"Jager","year":"2007","journal-title":"Endocrinology"},{"issue":"12","key":"2021121013261464700_B17","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2337\/diabetes.51.12.3391","article-title":"Interleukin-6 induces cellular insulin resistance in hepatocytes","volume":"51","author":"Senn","year":"2002","journal-title":"Diabetes"},{"issue":"2\u20133","key":"2021121013261464700_B18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/ENDO:23:2-3:177","article-title":"The role of TNF-\u03b1 in insulin resistance","volume":"23","author":"Borst","year":"2004","journal-title":"Endocrine"},{"key":"2021121013261464700_B19","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1038\/srep10096","article-title":"Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease","volume":"5","author":"Chang","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"2021121013261464700_B20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0953-6205(99)00064-3","article-title":"Serum complement protein C3 concentration is elevated in insulin resistance in obese men","volume":"11","author":"Koistinen","year":"2000","journal-title":"Eur J Intern Med"},{"issue":"12","key":"2021121013261464700_B21","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.1133870100","article-title":"Monocyte chemoattractant protein 1 in obesity and insulin resistance","volume":"100","author":"Sartipy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2021121013261464700_B22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjh.16786","article-title":"Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia","volume":"190","author":"Lopez","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"2021121013261464700_B23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00467-010-1690-z","article-title":"Pandemic H1N1 influenza A infection and (atypical) HUS\u2013more than just another trigger?","volume":"26","author":"Allen","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"2021121013261464700_B24","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00467-017-3783-4","article-title":"Influenza-associated thrombotic microangiopathies","volume":"33","author":"Bitzan","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"2021121013261464700_B25","first-page":"539","volume-title":"Kidney Int","author":"Goodship","year":"2017"},{"issue":"5","key":"2021121013261464700_B26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3476(88)80031-3","article-title":"Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study","volume":"113","author":"Van Damme-Lombaerts","year":"1988","journal-title":"J Pediatr"},{"issue":"5","key":"2021121013261464700_B27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2021121013261464700_B28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a target in COVID-19?","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2021121013261464700_B29","doi-asserted-by":"crossref","first-page":"e01753","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"MBio"},{"issue":"1","key":"2021121013261464700_B30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41426-018-0063-8","article-title":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV","volume":"7","author":"Jiang","year":"2018","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"2021121013261464700_B31","first-page":"e28","article-title":"The role of C5a in acute lung injury induced by highly pathogenic viral infections","volume":"4","author":"Wang","year":"2015","journal-title":"Emerg Microbes Infect"},{"issue":"7","key":"2021121013261464700_B32","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-016774\/1082510\/peds_2020016774.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-016774\/1082510\/peds_2020016774.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T02:44:40Z","timestamp":1639190680000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/147\/2\/e2020016774\/36266\/Toddler-With-New-Onset-Diabetes-and-Atypical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,1]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2020-016774","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"article-number":"e2020016774"}}